Lower price of Hexarelin Acetate for lose fat

Details:

Wuhan Xinru Chemical Industry Co.,Ltd  founded in 2006, engaged in R&D, producing and marketing barium salts, sodium salts, fertilizer and medical intermediates. 
We have several stock-holding factories, based on strong R&D ability, advanced production technology and experienced team; pluses international trade office in Wuhan, we can offer high and stable quality products with quick response and service. 

Since 2006,we have already developed and established a very good relationship with different reputed customers in EU, Egypt, Canada, Korea, USA, Chile, Turkey, Thailand etc.Our products widely used in water purification,magnet material, rubber, ceramic,glass,painting, powder coating, plastic industry, pharmacy and so on. 

OUR MISSION: satisfy customers needs ,serve wholeheartedly and sincerely. 
OUR SERVICE: supply excellent quality product with competitive price and fast 
shipment and timely delivery.

In the light of customer first, excellent quality, competitive price, good service, the principle of mutual benefit , to serve our new and old customers.

All we want is win-win busines.

Welcome to our company and warm welcome to inquiry me about all of our products, we will provide the competitive price for it.

We are sincerely responsible for the “Product quality and “After service".

Product Details:

Sequence: his-d-2-methyl-trp-ala-trp-d-phe-lys-nh2;

Molecular formula: c47h58n12o6;

Molar mass: 887.04022

Cas number: 140703-51-1

Pubchem: cid 5464109

Synonyms: hexarelin acetate, hex, examorelin

l-histidyl-2-methyl-d-tryptophyl-l-alanyl-l-tryptophyl-d-phenylalanyl-l-lysinamide

Secretagogue receptor is a g protein-coupled receptor that binds ghrelin and plays a role in energy homeostasis and regulation of body weight.

Hexarelin is a six-amino acid peptide. studies have shown that hexarelin is actually more effective and longer lasting than releasing hormone (ghrh). it is also known that ghrp-6 has a synergistic effect with ghrh, causing a far greater release than either of these substances alone.

 By combining ghrp-6 with hexarelin, a more potent gh releasing peptide combination is created than ever heard of. the potential clinical usefulness of these gh releasing hexapeptides is also reinforced by observations that long-term administration produces elevations in circulating igf-1 concentrations. long term treatment with ghrp-6 similarly has been shown to elevate serum igf-1 as well as igf-binding protein-3 concentrations and promote linear growth.

Application:

Ghrelin is an appetite-regulating factor secreted from peripheral organs that is involved in regulation of energy homoeostasis via binding to the receptor resulting in the secretion of by the pituitary gland. the pathway activated by binding of ghrelin to the secretagogue receptor, ghsr1a, regulates the activation of the downstream mitogen-activated protein kinase, akt, nitric oxide synthase, and ampk cascades in different cellular systems.

 One of the important features of ghsr1a displays constitutive activity possessing basal activity in the absence of an agonist, resulting in a high degree of receptor internalization as well as of signaling activity. inverse agonists for the ghrelin receptor could be particularly interesting for the treatment of obesity. this activity seems to provide a tonic signal required for the development of normal height, probably through an effect on the gh axis.

COA:

Conclusion: Complies with the manufacturer^’s standard.

Storage: 

Well-closed container at low temperature ( 2-8 degree), keep away from moisture, heat and light.